Complications associated with central venous catheters used for the collection of peripheral blood progenitor cells to support high-dose chemotherapy and autologous stem cell rescue

Supportive Care in Cancer

Volumn 5, Issue 3, 1997, Pages 223-227

  Meisenberg, Barry R ^a,b   Callaghan, Mary ^a   Sloan, Christine ^a   Sampson, Laurie ^a   Miller, William E ^a   McMillan, Robert ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER   (United States)

Author keywords

Central venous catheters; High dose chemotherapy; Stem cell transplant

Indexed keywords

ADULT; AGED; ARTICLE; CELL ISOLATION; CENTRAL VENOUS CATHETER; CENTRAL VENOUS CATHETERIZATION; DEEP VEIN THROMBOSIS; FEMALE; HEMATOTHORAX; HUMAN; INFECTIOUS COMPLICATION; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; PNEUMOTHORAX; PRIORITY JOURNAL; STEM CELL;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CATHETERIZATION, CENTRAL VENOUS; COMBINED MODALITY THERAPY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOTHORAX; HUMANS; INCIDENCE; INFECTION; LEUKAPHERESIS; MALE; MIDDLE AGED; PNEUMOTHORAX; THROMBOSIS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0030909130     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005200050064     Document Type: Article

References (8)

1. Bern MM, Lokich JJ, Wallach SR, Bothe A Jr, Benotti PA, Arkin CF, Greco FA, Huberman M, Moore C (1990) Very low doses of warfarin can prevent thrombosis in central venous catheters. Ann Intern Med 112,423-428
2. Chao NJ, Schriber JR, Grimes K, Long GD, Negrin RS, Raimondi CM, Horning SJ, Brown SL, Miller L, Blume KG (1993) Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after hish-dose chemotherapy. Blood 81:2031-2035
3. Dierks MM, Whitman ED (1995) Catheter tip position in the analysis of central venous access device outcome. J Venous Access Devises 1:11-14
4. Eastridge BJ, Lefor AT (1995) Complications of indwelling venous access devices in cancer patients. J Clin Oncol 13:233-238
5. Groeger JS, Lucas AB, Thaler HT, Friedlander-Klar H, Brown AE, Kiehn TE, Armstrong D (1993) Infectious morbidity associated with long-term use of venous access devices in patients with cancer. Ann Intern Med 119:1168-1174
6. Levine M, Hirsh J, Gent M, Arnold A, Warr D, Falanga A, Samosh M, Bramwell V, Pritchard KI, Stewart D, Goodwin P (1994) Double-blind randomized trial of very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer. Lancet 343:886-889
7. Peters WP, Rosner G, Ross M, Vredenburgh J, Meisenberg B, Gilbert C, Kurtzberg J (1993) Comparative effects of granulocyte-macrophage colony-stimulating factor (GM-CSF) and granulocyte colony-stimulating factor (G-CSF) on priming peripheral blood progenitor cells for use with autologous bone marrow after high-dose chemotherapy. Blood 81:1709-1719
8. Schmitz N, Linch DC, Dreger P, Goldstone AH, Boogaerts MA, Ferrant A, Demuynck HMS, Link H, Zander A, Barge A, Borkett K (1996) Randomized trial of filgrastim-mobilized peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients. Lancet 347:355-357